Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-007258
Filing Date
2025-11-25
Accepted
2025-11-25 12:06:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4663
  Complete submission text file 0001959173-25-007258.txt   6153
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-14656 | Film No.: 251516695
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O REPLIGEN CORPORATION 41 SEYON STREET, BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address
Loeillot Olivier (Reporting) CIK: 0001995525 (see all company filings)

Type: 144